source
- Biotech reverse mergers surge in 2026, reaching highest level since 2021 as PIPE financing spikesBiotech companies are using reverse mergers to re‑enter public markets at a rate not seen since 2021, according to a J.P. Morgan report released in October 2026. In the first nine months of 2026,…
- Roche builds blockbuster BTK case for fenebrutinib in multiple sclerosis as FDA decision approachesRoche has dived into the data behind its filing for FDA approval of fenebrutinib in multiple sclerosis, unpacking the BTK inhibitor’s effect on chronic active lesions, disease control and brain vol…Fierce Biotech · 5h ago↗ source